Search Count: 44
 |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.12 Å Release Date: 2025-04-30 Classification: CELL CYCLE Ligands: A1CAE |
 |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.98 Å Release Date: 2025-04-30 Classification: CELL CYCLE Ligands: A1CAH |
 |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.95 Å Release Date: 2025-04-30 Classification: CELL CYCLE Ligands: A1CAF |
 |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.10 Å Release Date: 2025-04-30 Classification: CELL CYCLE Ligands: A1CAG |
 |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.00 Å Release Date: 2025-04-30 Classification: CELL CYCLE Ligands: A1CAI |
 |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.24 Å Release Date: 2024-02-14 Classification: ONCOPROTEIN Ligands: GOL, GSH, WXQ |
 |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:3.33 Å Release Date: 2024-02-14 Classification: Transferase/Inhibitor Ligands: GOL, UIM, SO4 |
 |
Identification Of Gdc-1971 (Rly-1971), A Shp2 Inhibitor Designed For The Treatment Of Solid Tumors
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.40 Å Release Date: 2023-10-11 Classification: HYDROLASE Ligands: SO4, YR2 |
 |
Identification Of Gdc-1971 (Rly-1971), A Shp2 Inhibitor Designed For The Treatment Of Solid Tumors
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.84 Å Release Date: 2023-10-11 Classification: HYDROLASE Ligands: SO4, YT2 |
 |
Identification Of Gdc-1971 (Rly-1971), A Shp2 Inhibitor Designed For The Treatment Of Solid Tumors
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.10 Å Release Date: 2023-10-11 Classification: HYDROLASE Ligands: ZH5 |
 |
Identification Of Gdc-1971 (Rly-1971), A Shp2 Inhibitor Designed For The Treatment Of Solid Tumors
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.27 Å Release Date: 2023-10-11 Classification: HYDROLASE/INHIBITOR Ligands: ZJX |
 |
Discovery And Clinical Validation Of Rly-4008, The First Highly Selective Fgfr2 Inhibitor With Activity Across Fgfr2 Alterations And Resistance Mutations
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:3.79 Å Release Date: 2023-06-07 Classification: TRANSFERASE/INHIBITOR Ligands: WCJ |
 |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.16 Å Release Date: 2022-08-17 Classification: HYDROLASE/HYDROLASE INHIBITOR Ligands: GGU |
 |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.61 Å Release Date: 2022-08-17 Classification: HYDROLASE/HYDROLASE INHIBITOR Ligands: GJN |
 |
Taf1-Bd2 In Complex With Cpd27 (6-(But-3-En-1-Yl)-4-(1-Methyl-6-(Morpholine-4-Carbonyl)-1H-Benzo[D]Imidazol-4-Yl)-1,6-Dihydro-7H-Pyrrolo[2,3-C]Pyridin-7-One)
Organism: Oryctolagus cuniculus
Method: X-RAY DIFFRACTION Resolution:2.00 Å Release Date: 2018-11-14 Classification: Transcription/Inhibitor Ligands: G9V |
 |
Taf1-Bd2 In Complex With Cpd8 (6-(But-3-En-1-Yl)-4-(3-(Morpholine-4-Carbonyl)Phenyl)-1,6-Dihydro-7H-Pyrrolo[2,3-C]Pyridin-7-One)
Organism: Oryctolagus cuniculus
Method: X-RAY DIFFRACTION Resolution:1.30 Å Release Date: 2018-10-31 Classification: Transcription/Inhibitor Ligands: G9Y |
 |
Crebbp Bromodomain In Complex With Cpd3 ((S)-1-(3-(6-(1-Methyl-1H-Pyrazol-4-Yl)-3,4-Dihydroquinolin-1(2H)-Yl)-1-(Tetrahydrofuran-3-Yl)-1,4,6,7-Tetrahydro-5H-Pyrazolo[4,3-C]Pyridin-5-Yl)Ethan-1-One)
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.60 Å Release Date: 2018-03-07 Classification: TRANSCRIPTION REGULATOR/INHIBITOR Ligands: 9U7 |
 |
Crebbp Bromodomain In Complex With Cpd8 (1-(3-(7-(Difluoromethyl)-6-(1-Methyl-1H-Pyrazol-4-Yl)-3,4-Dihydroquinolin-1(2H)-Yl)-1-(Tetrahydrofuran-3-Yl)-1,4,6,7-Tetrahydro-5H-Pyrazolo[4,3-C]Pyridin-5-Yl)Ethan-1-One)
Organism: Mus musculus
Method: X-RAY DIFFRACTION Resolution:1.43 Å Release Date: 2018-03-07 Classification: TRANSFERASE/INHIBITOR Ligands: 9UA, DMS, GOL |
 |
Crebbp Bromodomain In Complex With Cpd10 (1-(3-(7-(Difluoromethyl)-6-(1-Methyl-1H-Pyrazol-4-Yl)-3,4-Dihydroquinolin-1(2H)-Yl)-1-(Tetrahydro-2H-Pyran-4-Yl)-1,4,6,7-Tetrahydro-5H-Pyrazolo[4,3-C]Pyridin-5-Yl)Ethan-1-One)
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.55 Å Release Date: 2018-03-07 Classification: TRANSCRIPTION REGULATOR/INHIBITOR Ligands: 9UD |
 |
Crebbp Bromodomain In Complex With Cpd17 (N,2,7-Trimethyl-2,3-Dihydro-4H-Benzo[B][1,4]Oxazine-4-Carboxamide)
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.70 Å Release Date: 2018-03-07 Classification: TRANSCRIPTION REGULATOR/INHIBITOR Ligands: SO4, 9UG |